Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

A broad semiconductor and AI-stock rebound, as concerns about slowing AI spending eased and chip-demand optimism returned, is driving AMD attention alongside strong bullish momentum and call activity. Traders are debating whether the move can extend toward a breakout, while others flag stretched valuation, overbought conditions, and the risk of a pullback.

A tech-led rebound after the Federal Reserves rate hike, aided by falling oil prices and Treasury yields, is driving attention to QQQ. Traders are split between viewing the move as a durable relief rally and seeing it as an overbought, algorithm-driven short squeeze vulnerable to volatility around the Bank of Japan decision and options expiration.

Anticipation of Starship Flight 14, now targeted for as early as Sept. 28 after another delay, is the dominant catalyst, with traders debating whether a successful mission could support momentum. Bulls also point to index-rebalance flows and SpaceXs Starlink expansion, while bears focus on launch risk, elevated valuation and upcoming lockup-related share supply.

Renewed enthusiasm for AI infrastructure and server demand is lifting SMCI alongside peers, with traders highlighting its low valuation, expected backlog growth, and heavy call activity as potential short-squeeze fuel. Bulls view the move as a breakout after prolonged range-bound trading, while skeptics point to possible ATM dilution, options-driven volatility, and repeated resistance near recent highs.

Barclays upgraded outlook, supported by a physician survey and anticipation of Iovances IOV-LUN-202 lung-cancer update, is driving attention alongside expectations for revised guidance and continued Amtagvi commercialization. Traders are broadly bullish on the companys pipeline and potential short covering, though some caution that profit-taking, options positioning, and clinical uncertainty could bring volatility.

Reported exploratory talks for SK Hynix to use Intels Ohio facilities or form a joint venture for U.S. memory-chip production are driving attention, with traders viewing the potential partnership as a boost to Intels foundry strategy amid strong AI-related memory demand. The community is broadly bullish and discussing short-covering and options-driven momentum, although skeptics note that SK Hynix says no specific plan or agreement has been finalized.

Exploratory partnership talks between SK Hynix and Intel to potentially manufacture memory chips in the United States are driving attention, alongside optimism about tight AI-related memory demand. Traders are broadly bullish on the memory sector, though some are cautioning that no agreement has been finalized and that the rally may be vulnerable to profit-taking and the ADRs premium to Korean shares.

The upcoming XP-8121 program overview is driving attention, with management expected to outline the pivotal Phase 3 design and commercialization strategy for its once-weekly injectable levothyroxine candidate. Traders are divided: bullish participants see major long-term potential alongside growing Recorlev sales, while skeptics view the projected 2030 launch timeline and added trial costs as limiting near-term upside; buyout speculation remains unconfirmed.

Uncertainty around Reddits renewal of its Google AI/data-licensing agreement is the dominant catalyst, with traders looking for concrete terms or a deal update. The CEOs comments that negotiations remain active, without a clear agreement, have fueled skepticism, while some bulls point to accelerating user growth and advertising momentum as offsets.

Rigetti is drawing attention after signing a definitive U.S. Department of Commerce agreement to fund superconducting quantum-computing research in exchange for a minority equity stake. Traders view the government backing as validation and a potential momentum catalyst for the broader quantum sector, while skeptics focus on share dilution, valuation, limited revenue, and execution risk.